Schroll Medical ApS is a Danish medical-cannabis producer, set up as a partnership between hydrangea grower Schroll Flowers and Canada’s Aphria, whose greenhouse in Årslev was EU-GMP certified by the Danish Medicines Agency in November 2019. In Portugal it works through Schroll Flavours – Produção e Comercialização de Produtos Agrícolas, Unipessoal Lda (NIF 509957650), a GACP-certified Algarve grower with an office in Olhão and production in Lagoa.
Schroll Medical grew out of Schroll Flowers, one of Europe’s largest hydrangea producers, and was set up as a partnership with Aphria Inc., the Canadian cannabis producer, announced in September 2018. Its large greenhouse at Kirstinebjergvej 33 in Årslev, on Funen, was EU-GMP certified by the Danish Medicines Agency in November 2019 and was described in 2020 as able to produce 6,000 kilograms of dried medical-cannabis flower a year. The company sells white-label medical cannabis, from flower to extract, and says it produces to the EU-GMP standard at sites in Denmark and Portugal.
The Portuguese arm is older than the cannabis business. Schroll Flavours – Produção e Comercialização de Produtos Agrícolas, Unipessoal Lda (NIF 509957650) was incorporated on 26 July 2011 and previously traded as Brian Knudsen – Comércio de Produtos Hortícolas and as Frigaard Fresh Produtos Hortícolas; its capital is now €300,000 and its main activity code is CAE 01280, aromatic, medicinal and pharmaceutical plants, with horticulture and fruit-and-vegetable wholesale as secondary codes. In September 2020 Sul Informação reported that a Schroll-Flowers group company was growing 36 hectares of hydrangeas in Olhão. Today Schroll Flavours describes itself as part of Schroll Medical and a GACP-certified grower of plant-based cannabinoids working towards EU-GMP certification, with its office at Quinta Ana Velha in Quelfes (Olhão) and production at Rua Carlos da Maia in Lagoa.
Schroll is a Danish grower that used the Algarve first for flowers and then for a regulated crop. Portugal has become Europe’s largest exporter of medical cannabis, much of it shipped to Germany, and a Danish producer with EU-GMP capacity at home and GACP cultivation in the Algarve shows how Nordic agri-businesses use southern Portugal’s climate and land to supply European pharmaceutical markets.
On 5 November 2020 AMP German Cannabis Group announced a non-exclusive, three-year supply agreement with Schroll Medical for EU-GMP cannabis flower to be sold under AMP’s brand in Germany. No newer dated announcement from Schroll Medical was found when this page was updated in October 2026.
Status: Compiled from public sources · Last verified: · Update this profile
Work at Schroll Medical? Send corrections or additions. Every update is checked before it is published; submissions are reviewed within a few working days.
Fractio helps Nordic companies enter the Portuguese market — from market sizing to first sales, hiring, and legal setup.
Talk to Fractio →